News

News
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
Partner news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story
In the media

At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience

Read full story
In the media

Medopad And Janssen Develop Automated Digital Test To Detect Alzheimer’s Earlier

Read full story
Other news

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story
Other news

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story
Partner news

Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.

Read full story
Partner news

TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform

Read full story
In the media

What’s Driving the Boom in Early Stage Biotech Funding?

Read full story
Partner news

AdoRx Therapeutics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics

Read full story